MATINAS BIOPHARMA HOLDINGS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Lessee, Operating Lease, Liability, to be Paid, Year One of $678.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-13
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $678.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $678.00K; Lessee, Operating Lease, Liability, to be Paid, Year One as first filed $781.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.04M.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.04M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One | Lessee, Operating Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2026-03-31 | $678.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $678.00K 10-Q · filed 2026-08-13 | $781.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.04M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.04M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.04M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $998.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $998.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $998.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $998.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $956.00K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $956.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $956.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $956.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $956.00K 10-K · filed 2024-03-27 | $916.00K 10-K · filed 2023-03-15 |
| 2022-09-30 | $916.00K 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $922.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $922.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $883.00K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $883.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $645.00K 10-Q · filed 2021-08-10 | |
| 2020-12-31 | $685.00K 10-K/A · filed 2022-03-11 | |
| 2019-12-31 | $753.00 10-Q · filed 2020-05-11 | $753.00K 10-K · filed 2020-03-09 |
| 2018-12-31 | $738.00K 10-K · filed 2020-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |